Loading organizations...
§ Private Profile · Chaoyang, Liaoning, China
Pharmaceutical company developing and commercializing medical products, expanding its women and children's healthcare portfolio.
Based in Beijing, China, GC-Rise Pharmaceutical is a privately held enterprise that develops and commercializes novel medical products focused specifically on the domestic women and children's healthcare markets. To support its core pharmaceutical operations, the organization actively expands its clinical product portfolio and builds an integrated online-to-offline distribution platform tailored for this specialized medical sector. The company has funded its commercialization efforts through venture capital, notably securing $15 million in Series B financing during September 2014 from lead institutional investor OrbiMed. In conjunction with this capital injection, OrbiMed executive Dr. Jonathan Wang joined the corporate board of directors to guide ongoing strategic expansion. Prior to this investment, the business was recognized by professional services network Deloitte as one of the top 50 fast-growing companies in China. GC-Rise Pharmaceutical was founded in 2008 by Wren Zhang.
GC-Rise Pharmaceutical has raised $15.0M across 1 funding round.
GC-Rise Pharmaceutical has raised $15.0M in total across 1 funding round.
GC-Rise Pharmaceutical has raised $15.0M in total across 1 funding round.
GC-Rise Pharmaceutical's investors include Jonathan Wang, Inventages, Yifang Group.
GC-Rise Pharmaceutical has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series B in September 2014.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 2, 2014 | $15M Series B | Jonathan Wang | Inventages, Yifang Group | Announced |